| abstract |
The present invention provides compounds of Formula O and various embodiments thereof, and compositions comprising compounds of Formula O and various embodiments thereof. In the compounds of formula 0, the groups R1A, R1B, R1C, R1D, R2, R3, R4, R5 and R6 have the meanings as described herein. The present invention also provides methods of using compounds of Formula O and compositions comprising compounds of Formula O as DLK inhibitors and for the treatment of neurodegenerative diseases and disorders. |